SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
复制标题
DOI:
10.1136/bmjopen-2020-045105
复制
发表时间:
2021-06-30
期刊:
影响因子:
2.9
通讯作者:
Wenzel L
中科院分区:
文献类型:
--
作者:
Calvert M;King M;Mercieca-Bebber R;Aiyegbusi O;Kyte D;Slade A;Chan AW;Basch E;Bell J;Bennett A;Bhatnagar V;Blazeby J;Bottomley A;Brown J;Brundage M;Campbell L;Cappelleri JC;Draper H;Dueck AC;Ells C;Frank L;Golub RM;Griebsch I;Haywood K;Hunn A;King-Kallimanis B;Martin L;Mitchell S;Morel T;Nelson L;Norquist J;O'Connor D;Palmer M;Patrick D;Price G;Regnault A;Retzer A;Revicki D;Scott J;Stephens R;Turner G;Valakas A;Velikova G;von Hildebrand M;Walker A;Wenzel L
Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on the impact of disease and treatment on patients’ symptoms, function and quality of life. High-quality PRO data from trials can inform shared decision-making, regulatory and economic analyses and health policy. Recent evidence suggests the PRO content of past trial protocols was often incomplete or unclear, leading to research waste. To address this issue, international, consensus-based, PRO-specific guidelines were developed: the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-PRO Extension. The SPIRIT-PRO Extension is a 16-item checklist which aims to improve the content and quality of aspects of clinical trial protocols relating to PRO data collection to minimise research waste, and ultimately better inform patient-centred care. This SPIRIT-PRO explanation and elaboration (E&E) paper provides information to promote understanding and facilitate uptake of the recommended checklist items, including a comprehensive protocol template. For each SPIRIT-PRO item, we provide a detailed description, one or more examples from existing trial protocols and supporting empirical evidence of the item’s importance. We recommend this paper and protocol template be used alongside the SPIRIT 2013 and SPIRIT-PRO Extension paper to optimise the transparent development and review of trial protocols with PROs.
登录
查看更多内容
影响因子:
3.7
作者:
Calvert M;Kyte D;Duffy H;Gheorghe A;Mercieca-Bebber R;Ives J;Draper H;Brundage M;Blazeby J;King M
通讯作者:
King M
影响因子:
3.8
作者:
Collinson, Fiona J.;Gregory, Walter M.;Brown, Janet
通讯作者:
Brown, Janet
影响因子:
51.1
作者:
Bottomley, Andrew;Pe, Madeline;Coens, Corneel
通讯作者:
Coens, Corneel
影响因子:
3
作者:
Brooks, MM;Jenkins, LS;Paeth, DS
通讯作者:
Paeth, DS
DOI:
10.1136/bmj.d1828
发表时间:
2011-04-05
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Blümle A;Meerpohl JJ;Rücker G;Antes G;Schumacher M;von Elm E
通讯作者:
von Elm E